Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,453-1,464 of 1,909
Drug study icon
CompletedEUCTR 2013-002228-18

A randomized controlled clinical trial for assessing the effectiveness of pharmacogenetic information obtained with NEUROFARMAGEN in the treatment of patients with mental disorders

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, OCD, ...DrugA study involving a medication or substance.
Countries
Spain
Sponsor
AB-BIOTICS S.A.
Condition
Depression, OCD, ...
Drug study icon
CompletedEUCTR 2006-000846-38

A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Extended-Release Paliperidone as Maintenance Treatment After an ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrug
Countries
Germany
Sponsor
Janssen-Cilag International N.V.
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2005-005812-25

A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexi...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Greece
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrug
Countries
Greece, Lithuania
Sponsor
Janssen-Cilag International N.V.
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2006-001490-15

A randomized, double-blind, placebo- and active-controlled, parallel-group study to evaluate the efficacy and safety of risperidone long-acting injectable for the prevention of mood episodes in the...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrug
Countries
Germany, Greece
Sponsor
Janssen-Cilag International N.V
Condition
Bipolarity
Drug study icon
TerminatedEUCTR 2004-000114-40

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of licarbazepine 750-2500 mg/d combined with lithium or valproate in the treatmen...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrug
Countries
Austria, Czechia, Slovakia
Sponsor
Novartis Pharma AG
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2005-005345-19

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood S...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrug
Countries
Belgium, Estonia
Sponsor
Janssen-Cilag International N.V.
Condition
Bipolarity
Drug study icon
TerminatedEUCTR 2006-006940-69

Add-on treatment of mental illness with anti-viral medicine

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sweden
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrug
Countries
Sweden
Sponsor
Lund University Hospital
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedEUCTR 2007-007555-14

An 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as Adjunctive Therapy in Adults With Major ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Bulgaria, Hungary
Sponsor
Cephalon, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2004-004909-16

An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
United Kingdom
Sponsor
AstraZeneca AB
Condition
Depression, Bipolarity
Biological study icon
CompletedEUCTR 2016-002326-36

Effects of erythropoietin (EPO) on cognitive side-effects of electroconvulsive therapy (ECT) (EPO-T)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionBiological
Countries
Denmark
Sponsor
Region Hovedstadens psykiatriske hospital
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2007-006561-32

Effects of intranasal application of oxytocin on empathy and mentalising in patients with psychotic disorders and severe personality disorders

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, Bipolarity, ...Drug
Countries
Germany
Sponsor
LWL University Hospital Bochum
Condition
Schizophrenia, Bipolarity, ...
Drug study icon
TerminatedEUCTR 2006-006426-26

FAST – A randomised, open-label, parallel, multicentre Phase IIIb Study to evaluate the Efficacy and Safety of Quetiapine IR titrared over 4 Days in Patients with Acute Psychosis (Rapid versus Conv...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Sweden
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrug
Countries
Sweden
Sponsor
AstraZeneca AB
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.